Skip to main content
Caplight Logo









EPINTEK

EPINTEK

Private
ShanghaiHealthcare & Life Scienceshttps://epintek.com/

Last Round

Series C

Extension

Aug 28, 2023

Total Funding Raised

$18.45M

Company Overview

EPINTEK is a healthcare services company that provides contract research organization (CRO) services, including preclinical research, analytical testing, regulatory strategy, and clinical trials for medical device and biomedical companies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Compliance, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROmedical device testingregulatory consultingclinical trial managementbiocompatibility testingmedical device registrationCDMOcontract development and manufacturingpreclinical researchmedical device compliancelab testing servicesmedtech consultingregulatory affairsbiostatistics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EPINTEK Comparables

Compare EPINTEK with similar companies based on industry and business-model similarity.

EPINTEK comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.
93%
天津海河生物医药科技集团有限公司
88%
Osmunda Medical Device Service Group
83%

EPINTEK Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionAug 28, 2023
Series C ExtensionJan 30, 2022

Key People

Founding team and executive leadership

Yu Rui

Chief Executive Officer

Executive Team

EPINTEK Investors

Notable investors and investment history

EPINTEK investors
InvestorRounds
October CapitalSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2025

    Monthly visitors grew 1445% MoM, from 123 to 1.9K.

  • Aug 28, 2023

    $2.75M round led by October Capital

EPINTEK Filings

Explore SEC and related filing metadata, where available.

EPINTEK filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EPINTEK's valuation, stock price, and market status.

Is EPINTEK a public or private company?

EPINTEK is a private company.

What is the current stock price of EPINTEK?

EPINTEK is a private company with no public stock price. Caplight tracks EPINTEK's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is EPINTEK worth (valuation)?

Valuation information for EPINTEK is not publicly available.

Can I buy EPINTEK stock?

EPINTEK shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EPINTEK's last funding round?

EPINTEK's most recent funding round was Series C Extension on August 28, 2023.

Who are the main investors in EPINTEK?

Key investors in EPINTEK include October Capital.

Will EPINTEK IPO soon?

No public IPO plans have been announced for EPINTEK.

How can I track EPINTEK secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EPINTEK's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2020
Last FundingAug 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?